Primary Peritoneal Carcinoma — Trials

Primary Peritoneal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

294 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 92
Recruiting: 35
Ph III recruiting: 5
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (46)

clinicaltrialsPublishedShowing 101–141 of 141 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03312114	Anti-PD-L1 and SAbR for Ovarian Cancer	terminated	Phase 2	5	University of Texas Southwestern Medical CenterOTHER	1	Nov 12, 2020	clinicaltrials
NCT02283658	Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer	completed	Phase 2	20	Mayo ClinicOTHER	1	Oct 23, 2020	clinicaltrials